SMI's Bilayer Nova development and pilot-scale double-layered tablet press is fully automated.
The Bilayer Nova from SMI is a fully automated development and pilot-scale double-layered tablet press with single-layer capabilities. The intuitive human-machine-interface control touchscreen allows full visible access of the machine with accesible controls. The standalone unit does not require any additional consoles or cabinets, which is ideal for tight working environments. The machine has nine-ton, first- and second-layer compression capabilities that are suitable for bilayer tableting requirements. New 'Director Pro' software is designed to reduce operator error and increase product yield. The software will automatically maintain individual tablet weights and reject tablets that are outside of user-specified tolerances.
Telix Enters Agreement with ImaginAb to Purchase Next-Gen Therapeutic Candidates
Published: January 13th 2025 | Updated: January 13th 2025The transaction adds a pipeline of early-stage drug candidates against high-value targets to Telix’s portfolio, along with other novel targets currently in the discovery stage.